List view / Grid view
25 November 2015 | By Victoria White
The transaction, expected to complete next month, is aimed at strengthening ReproCELL’s pharmaceutical industry-targeted drug discovery services...
25 November 2015 | By
Ablynx and Novo Nordisk hope to discover and develop novel multi-specific drug candidates using Ablynx's proprietary Nanobody technology...
22 November 2015 | By Illumina
In this webinar, we focus on the use of microarray technology in drug development...
20 November 2015 | By Victoria White
The company has announced three new partnerships that will deliver a collaborative screening platform, space-age robotics, and sound waves that can move liquids...
16 November 2015 | By Victoria White
Researchers have created molecules that mimic and dominate toxic ones secreted by bacteria. The implications for the study of biology and pharmacology are said to be enormous...
11 November 2015 | By Victoria White
Of the total investment, EUR 5 billion will go to preclinical R&D with EUR 1.5 billion thereof planned for collaborations with external partners...
10 November 2015 | By Victoria White
The initiative aims to accelerate research into biology's "invisible mass" to provide novel insights into cell function and a new frontier in drug discovery...
4 November 2015 | By Victoria White
IPC will perform chemo-informatic virtual screening of a pre-selected Eisai chemical library, to identify new protein-protein inhibitors for further biological evaluation...
3 November 2015 | By Victoria White
The aim of the collaboration is to deliver potential first-in-class small molecules as lead candidate drugs for multiple oncology indications...
29 October 2015 | By Victoria White
Domainex is expanding all aspects of its drug discovery service business including biology, analytical chemistry and medicinal chemistry...
28 October 2015 | By Victoria White
Researchers have identified a molecule that, after a stroke, initiate repairs to the brain...
23 October 2015 | By Victoria White
The work paves the way for personalised drug discovery for kidney disease...
22 October 2015 | By Victoria White
Scientists have isolated the gene that produces Gasdermin-D - a protein that plays a critical role in the pathway to sepsis...
21 October 2015 | By Kate Douetil
This innovative new global investment fund has gained support from a wide variety of investors, including the UK Government’s Department of Health (DoH), Alzheimer’s Research UK and world-leading major pharmaceutical companies Biogen, GlaxoSmithKline, Johnson & Johnson, Lilly, Pfizer and Takeda...
20 October 2015 | By Victoria White
Domainex has been selected as Imperial’s strategic drug discovery partner to provide services including biochemical and biophysical assay development...
